As of 2024-12-13, the Relative Valuation of Fulgent Genetics Inc (FLGT) is (145.20) USD. This relative valuation is based on P/E multiples. With the latest stock price at 20.24 USD, the upside of Fulgent Genetics Inc based on Relative Valuation is -817.4%.
The range of the Relative Valuation is (130.51) - (169.88) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 24.2x - 35.1x | 27.6x |
| Forward P/E multiples | 23.6x - 31.5x | 26.2x |
| Fair Price | (130.51) - (169.88) | (145.20) |
| Upside | -744.8% - -939.3% | -817.4% |
| Date | P/E |
| 2024-12-10 | -3.75 |
| 2024-12-09 | -3.89 |
| 2024-12-06 | -3.73 |
| 2024-12-05 | -3.65 |
| 2024-12-04 | -3.75 |
| 2024-12-03 | -3.63 |
| 2024-12-02 | -3.63 |
| 2024-11-29 | -3.39 |
| 2024-11-27 | -3.35 |
| 2024-11-26 | -3.32 |
| 2024-11-25 | -3.40 |
| 2024-11-22 | -3.31 |
| 2024-11-21 | -3.14 |
| 2024-11-20 | -3.20 |
| 2024-11-19 | -3.15 |
| 2024-11-18 | -3.10 |
| 2024-11-15 | -3.21 |
| 2024-11-14 | -3.30 |
| 2024-11-13 | -3.42 |
| 2024-11-12 | -3.55 |
| 2024-11-11 | -3.72 |
| 2024-11-08 | -3.60 |
| 2024-11-07 | -4.08 |
| 2024-11-06 | -4.21 |
| 2024-11-05 | -4.08 |
| 2024-11-04 | -4.00 |
| 2024-11-01 | -4.01 |
| 2024-10-31 | -3.98 |
| 2024-10-30 | -3.76 |
| 2024-10-29 | -3.71 |
| 2024-10-28 | -3.69 |
| 2024-10-25 | -3.60 |
| 2024-10-24 | -3.55 |
| 2024-10-23 | -3.56 |
| 2024-10-22 | -3.63 |
| 2024-10-21 | -3.58 |
| 2024-10-18 | -3.66 |
| 2024-10-17 | -3.65 |
| 2024-10-16 | -3.73 |
| 2024-10-15 | -3.76 |
| 2024-10-14 | -3.77 |
| 2024-10-11 | -3.68 |
| 2024-10-10 | -3.71 |
| 2024-10-09 | -3.69 |
| 2024-10-08 | -3.81 |
| 2024-10-07 | -3.80 |
| 2024-10-04 | -3.87 |
| 2024-10-03 | -3.81 |
| 2024-10-02 | -3.92 |
| 2024-10-01 | -3.91 |